Cartesian Therapeutics, Inc.RNACNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank82
3Y CAGR+5.5%
5Y CAGR-2.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+5.5%/yr
vs +29.9%/yr prior
5Y CAGR
-2.0%/yr
Recent acceleration
Acceleration
-24.3pp
Decelerating
Percentile
P82
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $125.14M | -41.1% |
| 2024 | $212.61M | +176.4% |
| 2023 | $76.91M | -27.7% |
| 2022 | $106.44M | -6.7% |
| 2021 | $114.06M | -17.8% |
| 2020 | $138.69M | +53.8% |
| 2019 | $90.17M | +141.1% |
| 2018 | $37.40M | -47.1% |
| 2017 | $70.70M | +20.5% |
| 2016 | $58.66M | - |